These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 33644623)

  • 21. Flash Continuous Glucose Monitoring: A Summary Review of Recent Real-World Evidence.
    Bailey CJ; Gavin JR
    Clin Diabetes; 2021 Jan; 39(1):64-71. PubMed ID: 33551555
    [TBL] [Abstract][Full Text] [Related]  

  • 22. How Can We Realize the Clinical Benefits of Continuous Glucose Monitoring?
    Ajjan RA
    Diabetes Technol Ther; 2017 May; 19(S2):S27-S36. PubMed ID: 28541132
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of Frequent and Persistent Use of Continuous Glucose Monitoring (CGM) on Hypoglycemia Fear, Frequency of Emergency Medical Treatment, and SMBG Frequency After One Year.
    Chamberlain JJ; Dopita D; Gilgen E; Neuman A
    J Diabetes Sci Technol; 2015 Sep; 10(2):383-8. PubMed ID: 26353781
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis Estimating the Potential Cost Impact of Utilizing Flash Glucose Monitoring with Optional Alarms in Swedish Adults with Diabetes with Impaired Awareness of Hypoglycaemia, Using Intensive Insulin.
    Blissett DB; Attvall S; Hellmund RA
    Diabetes Ther; 2021 Aug; 12(8):2179-2193. PubMed ID: 34232483
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CONTINUOUS GLUCOSE MONITORING: A CONSENSUS CONFERENCE OF THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY.
    Fonseca VA; Grunberger G; Anhalt H; Bailey TS; Blevins T; Garg SK; Handelsman Y; Hirsch IB; Orzeck EA; Roberts VL; Tamborlane W;
    Endocr Pract; 2016 Aug; 22(8):1008-21. PubMed ID: 27214060
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HypoDE: Research Design and Methods of a Randomized Controlled Study Evaluating the Impact of Real-Time CGM Usage on the Frequency of CGM Glucose Values <55 mg/dl in Patients With Type 1 Diabetes and Problematic Hypoglycemia Treated With Multiple Daily Injections.
    Heinemann L; Deiss D; Hermanns N; Graham C; Kaltheuner M; Liebl A; Price D
    J Diabetes Sci Technol; 2015 May; 9(3):651-62. PubMed ID: 25759183
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial.
    Feig DS; Donovan LE; Corcoy R; Murphy KE; Amiel SA; Hunt KF; Asztalos E; Barrett JFR; Sanchez JJ; de Leiva A; Hod M; Jovanovic L; Keely E; McManus R; Hutton EK; Meek CL; Stewart ZA; Wysocki T; O'Brien R; Ruedy K; Kollman C; Tomlinson G; Murphy HR;
    Lancet; 2017 Nov; 390(10110):2347-2359. PubMed ID: 28923465
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glucose sensor-augmented continuous subcutaneous insulin infusion in patients with diabetic gastroparesis: An open-label pilot prospective study.
    Calles-Escandón J; Koch KL; Hasler WL; Van Natta ML; Pasricha PJ; Tonascia J; Parkman HP; Hamilton F; Herman WH; Basina M; Buckingham B; Earle K; Kirkeby K; Hairston K; Bright T; Rothberg AE; Kraftson AT; Siraj ES; Subauste A; Lee LA; Abell TL; McCallum RW; Sarosiek I; Nguyen L; Fass R; Snape WJ; Vaughn IA; Miriel LA; Farrugia G;
    PLoS One; 2018; 13(4):e0194759. PubMed ID: 29652893
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of technology on glycaemic control in type 2 diabetes: A meta-analysis of randomized trials on continuous glucose monitoring and continuous subcutaneous insulin infusion.
    Dicembrini I; Mannucci E; Monami M; Pala L
    Diabetes Obes Metab; 2019 Dec; 21(12):2619-2625. PubMed ID: 31368658
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Flash Glucose Monitoring System for People with Type 1 or Type 2 Diabetes: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2019; 19(8):1-108. PubMed ID: 31942227
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Continuous Glucose Monitoring Versus Capillary Point-of-Care Testing for Inpatient Glycemic Control in Type 2 Diabetes Patients Hospitalized in the General Ward and Treated With a Basal Bolus Insulin Regimen.
    Gómez AM; Umpierrez GE; Muñoz OM; Herrera F; Rubio C; Aschner P; Buendia R
    J Diabetes Sci Technol; 2015 Aug; 10(2):325-9. PubMed ID: 26330394
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inpatient Continuous Glucose Monitoring and Glycemic Outcomes.
    Levitt DL; Silver KD; Spanakis EK
    J Diabetes Sci Technol; 2017 Sep; 11(5):1028-1035. PubMed ID: 28290224
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypoglycemic Event Frequency and the Effect of Continuous Glucose Monitoring in Adults with Type 1 Diabetes Using Multiple Daily Insulin Injections.
    Riddlesworth T; Price D; Cohen N; Beck RW
    Diabetes Ther; 2017 Aug; 8(4):947-951. PubMed ID: 28616804
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Titration of Long-Acting Insulin Using Continuous Glucose Monitoring and Smart Insulin Pens in Type 1 Diabetes: A Model-Based Carbohydrate-Free Approach.
    El Fathi A; Fabris C; Breton MD
    Front Endocrinol (Lausanne); 2021; 12():795895. PubMed ID: 35082757
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clustering of Hypoglycemia Events in Patients With Hyperinsulinism: Extension of the Digital Phenotype Through Retrospective Data Analysis.
    Worth C; Harper S; Salomon-Estebanez M; O'Shea E; Nutter PW; Dunne MJ; Banerjee I
    J Med Internet Res; 2021 Oct; 23(10):e26957. PubMed ID: 34435596
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety comparison of continuous glucose monitoring and self-monitoring of blood glucose in type 1 diabetes: systematic review and meta-analysis.
    Wojciechowski P; Ryś P; Lipowska A; Gawęska M; Małecki MT
    Pol Arch Med Wewn; 2011 Oct; 121(10):333-43. PubMed ID: 22045094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systematic review and meta-analysis of the effectiveness of continuous glucose monitoring (CGM) on glucose control in diabetes.
    Poolsup N; Suksomboon N; Kyaw AM
    Diabetol Metab Syndr; 2013; 5():39. PubMed ID: 23876067
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Effect of Prior Continuous Glucose Monitoring Use on Glycemic Outcomes in the Pivotal Trial of the MiniMed
    Cordero TL; Garg SK; Brazg R; Bailey TS; Shin J; Lee SW; Kaufman FR
    Diabetes Technol Ther; 2017 Dec; 19(12):749-752. PubMed ID: 29148821
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Impact of Real-Time Continuous Glucose Monitoring in Patients 65 Years and Older.
    Polonsky WH; Peters AL; Hessler D
    J Diabetes Sci Technol; 2016 Jul; 10(4):892-7. PubMed ID: 27022095
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.